Status
Conditions
About
Building a Microbiome Data Platform and Conducting Clinical Evidence Research in Individuals Infected with the Human Immunodeficiency Virus (HIV) and Hepatitis B virus.
Full description
Chronic HIV infection, which often results in metabolic disorders, leads to shifts in the gut microbiota, contributing to immune activation and chronic inflammation. This study seeks to compare the gut microbiota in individuals with chronic HIV infection and chronic hepatitis B patients. The objective is to identify specific gut bacterial strains and metabolic pathways linked to the metabolic disorders commonly observed in HIV patients.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
HIV patients
HBV patients
Exclusion criteria
200 participants in 2 patient groups
Loading...
Central trial contact
Bomi Kim, M.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal